Apollomics, Inc.
APLM · NASDAQ
12/31/2024 | 6/30/2024 | 12/31/2023 | 6/30/2023 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $10 | $26 | $32 | $25 |
| Short-Term Investments | $0 | $0 | $6 | $27 |
| Receivables | $0 | $0 | $0 | $1 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $0 | $2 | $2 | $2 |
| Total Curr. Assets | $10 | $28 | $40 | $55 |
| Property Plant & Equip (Net) | $1 | $1 | $1 | $1 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $2 | $5 | $15 | $15 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $3 | $6 | $15 | $16 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $13 | $35 | $55 | $71 |
| Liabilities | – | – | – | – |
| Payables | $0 | $0 | $0 | $1 |
| Short-Term Debt | $0 | $4 | $4 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $7 | $9 | $9 | $13 |
| Total Curr. Liab. | $7 | $13 | $14 | $14 |
| LT Debt | $1 | $1 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $1 |
| Total NC Liab. | $1 | $1 | $1 | $2 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $1 | $1 | $0 | $1 |
| Total Liabilities | $8 | $14 | $14 | $16 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$701 | -$682 | -$647 | -$625 |
| AOCI | $3 | $36 | $3 | $19 |
| Other Equity | $702 | $1,333 | $685 | $661 |
| Total Equity | $5 | $21 | $41 | $56 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $13 | $35 | $55 | $71 |
| Net Debt | -$9 | -$21 | -$27 | -$25 |